Q&A: How FDA decision is speeding development of new osteoporosis drugs

Osteoporosis weakens bones and makes them more likely to break. The disease affects about 10 million Americans over age 50, including one in five women. And those numbers are expected to rise as the share of Americans 65 and older climbs from 18.9% to 23.4% by 2060.